Biotransformation of tri-substituted methoxyamphetamines by Cunninghamella echinulata. 1992

B C Foster, and J McLeish, and D L Wilson, and L W Whitehouse, and J Zamecnik, and B A Lodge
Bureau of Drug Research, Sir Frederick Banting Research Centre, Health Protection Branch, Ottawa, Ontario, Canada.

1. Four trimethoxyamphetamine analogues were incubated with the filamentous fungus Cunninghamella echinulata. 2. 2,4,5-Trimethoxyamphetamine and 2,5-dimethoxy-4-ethoxyamphetamine were poorly metabolized by C. echinulata ATCC 9244 and C. echinulata var. elegans ATCC 9245. 2,5-Dimethoxy-4-(n)-propoxyamphetamine was mainly metabolized through N-acetylation and O-dealkylation with minor amounts of several aliphatic hydroxylation metabolites formed. 2,5-Dimethoxy-4-methylthioamphetamine was extensively metabolized to the corresponding sulphoxide. 3. 2,5-Dimethoxy-4-methylthioamphetamine metabolism was inhibited by ethanol and quinidine. Sparteine did not inhibit the formation of the sulphoxide and may have shunted the substrate through alternate metabolic pathways. 4. Incubation conditions can affect the rate and extent of fungal biotransformation of 2,5-dimethoxy-4-methylthioamphetamine, and influence dextrose utilization, ammonia formation and pH.

UI MeSH Term Description Entries
D009090 Mucorales An order of zygomycetous fungi, usually saprophytic, causing damage to food in storage, but which may cause respiratory infection or MUCORMYCOSIS in persons suffering from other debilitating diseases. Mucoraceae,Thamnidiaceae
D000662 Amphetamines Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

B C Foster, and J McLeish, and D L Wilson, and L W Whitehouse, and J Zamecnik, and B A Lodge
October 1991, Canadian journal of microbiology,
B C Foster, and J McLeish, and D L Wilson, and L W Whitehouse, and J Zamecnik, and B A Lodge
March 2016, Fitoterapia,
B C Foster, and J McLeish, and D L Wilson, and L W Whitehouse, and J Zamecnik, and B A Lodge
March 1990, Pharmaceutical research,
B C Foster, and J McLeish, and D L Wilson, and L W Whitehouse, and J Zamecnik, and B A Lodge
January 2012, Journal of Asian natural products research,
B C Foster, and J McLeish, and D L Wilson, and L W Whitehouse, and J Zamecnik, and B A Lodge
January 2017, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology],
B C Foster, and J McLeish, and D L Wilson, and L W Whitehouse, and J Zamecnik, and B A Lodge
October 1991, Xenobiotica; the fate of foreign compounds in biological systems,
B C Foster, and J McLeish, and D L Wilson, and L W Whitehouse, and J Zamecnik, and B A Lodge
November 1992, Xenobiotica; the fate of foreign compounds in biological systems,
B C Foster, and J McLeish, and D L Wilson, and L W Whitehouse, and J Zamecnik, and B A Lodge
January 2023, Natural product research,
B C Foster, and J McLeish, and D L Wilson, and L W Whitehouse, and J Zamecnik, and B A Lodge
February 2021, Phytochemistry,
B C Foster, and J McLeish, and D L Wilson, and L W Whitehouse, and J Zamecnik, and B A Lodge
September 2010, Journal of bioscience and bioengineering,
Copied contents to your clipboard!